Celecoxib

Overview

Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase-2 (COX-2), leading to decreased formation of prostaglandins involved in inflammation and pain. It is commonly used to treat conditions such as osteoarthritis, rheumatoid arthritis, and acute pain.

API suppliers (29)

Suppliers of Celecoxib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Micro Labs Usa2 active DMF
• PHARMAZELL INDIA PRIVATE LTDIndia1 active DMF GMP on record
• AARTI DRUGS LTDIndia1 active DMF GMP on record
• Jiangxi Synergy Pharmaceutical Co., LtdChina1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• Lupin LimitedIndia1 active DMF GMP on record
• Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
• Hetero Drugs LimitedIndia1 active DMF GMP on record
• Cadila Pharmaceuticals LimitedIndia1 active DMF GMP on record
• AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)India1 active DMF
• Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
• INTERQUIM SAPeru1 active DMF GMP on record
• Cipla USA, Inc.USA1 active DMF
• SAURAV CHEMICALS LTD1 active DMF GMP on record
• TIANJIN TIANYAO PHARMACEUTICALS CO LTDChina1 active DMF
• SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
• SCINOPHARM TAIWAN LTDTaiwan1 active DMF
• HIKAL LTDPakistan1 active DMF
• Unichem Laboratories Ltd.India1 active DMF GMP on record
• AURORE LIFE SCIENCES PRIVATE LTD1 active DMF GMP on record
• HENAN DONGTAI PHARM CO LTDChina1 active DMF
• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
• CHEMECA DRUGS PRIVATE LTDIndia1 active DMF
• HISUN PHARMACEUTICAL NANTONG CO LTD

Showing 25 of 29 suppliers — see the full list in the app.

EU CEP holders (24)

Companies holding a valid EU Certificate of Suitability (CEP) for Celecoxib, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (73 approved US products), the latest listed US patent on Celecoxib expires 17 Sept 2045. Generic API sourcing typically opens up once these lapse.

Therapeutic areas